ArticleInflammation2026

Deucravacitinib Inhibits Synovial Fibroblast Activation Via TYK2/STAT3 and PI3K/Akt Signaling Pathway.

Zechao Qu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.